The ASH Award for Research Careers in Hematology (ARCH) succeeds the ASH Bridge Grant program, introducing refinements that include decoupling the program from the National Institutes of Health R01 funding mechanism. ARCH is now an independent award designed to make research in hematology more accessible to independent investigators.
The award provides $150,000 in funding, which may be used over a period of 1, 2, or 3 years depending on the recipient’s preference. It is available to researchers who are no longer eligible for the ASH AIMFD and ASH Scholar Awards who hold a PharmD, a PhD, an MD/DO, or an MD/DO—PhD.
Applicants must submit proposals for research in hematology, which may fall into the following categories: Basic research, translational research, patient-oriented research, and/or outcomes-based research.
Deadlines: March 31, 2026
Applicants must be a U.S. or Canadian citizen or hold a visa or permanent resident status in the US, Mexico, or Canada with plans to conduct research within the US, Mexico, or Canada. Applicants must serve as the Principal Investigator (PI) on the project, have completed residency or their terminal degree more than 13 years ago, hold a position at an academic institution or an equivalent position at a non-profit research organization, and have $500,000 or less in other resources available.
Sponsor Institute/Organizations: American Society of Hematology
Sponsor Type:
Address: 2021 L Street NW, Suite 900, Washington, DC 20036
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 31, 2026
Mar 31, 2026
$150,000
Affiliation: American Society of Hematology
Address: 2021 L Street NW, Suite 900, Washington, DC 20036
Website URL: https://www.hematology.org/awards/career-enhancement-and-training/scholar-award
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.